Activation of cyclophosphamide in man and animals.
D000328:Adult; D000478:Alkylation; D000818:Animals; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000378:metabolism*; D005260:Female; D005706:Gallbladder Neoplasms / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D008954:Models, Biological; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D009578:Nitrobenzenes / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011743:Pyrimidines / Q000378:metabolism; D051381:Rats; D012878:Skin Neoplasms / Q000188:drug therapy; D013997:Time Factors
D009578:Nitrobenzenes; D011743:Pyrimidines; D003520:Cyclophosphamide